House Commerce Cmte. Launches Inquiry Into FDA Single-Use, Reuse Regs
This article was originally published in The Gray Sheet
House Commerce Committee members will decide whether to hold a hearing on FDA regulation of reprocessed single-use medical devices after they receive a response from FDA Commissioner Jane Henney to a Dec. 8 request for information.
You may also be interested in...
The Senate Health, Education, Labor and Pensions Committee will ask the General Accounting Office to undertake a comprehensive evaluation of the practice of reprocessing devices, according to committee staffers.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.